Dashboard
Manage Tickers

BWAY Brainsway Ltd.

Nasdaq brainsway.com


$ 16.86 $ -0.14 (-0.82 %)    

Friday, 31-Oct-2025 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 16.85
$ 16.82
$ 16.50 x 2
$ 17.55 x 4
$ 16.65 - $ 16.99
$ 7.84 - $ 17.49
22,310
na
317M
$ 1.27
$ 108.53
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

brainsway-announces-strategic-investment-in-heading-health-commits-up-to-4m-to-expand-mental-health-clinic-network
BrainsWay Announces Strategic Investment I...
10/27/2025 11:46:56

Recent agreements with two additional U.S. mental health providers bring total to four in 2025Strategy seeks to drive long-term...

brainsway-announces-fda-granted-expansion-of-cleared-treatment-protocols-for-the-companys-deep-tms-to-include-accelerated-protocol-for-major-depressive-disorder
BrainsWay Announces FDA Granted Expansion ...
09/16/2025 12:33:12

hc-wainwright--co-reiterates-buy-on-brainsway-maintains-17-price-target
HC Wainwright & Co. Reiterates Buy on Brai...
08/25/2025 11:03:05

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $17 price tar...

brainsway-announces-strategic-investment-in-neurolief-ahead-of-fda-approval-and-commercial-launch-of-proliv-rx-for-major-depressive-disorder
BrainsWay Announces Strategic Investment I...
08/21/2025 13:34:33

 Neurolief, a pioneering brain stimulation company specializing in non-invasive neuromodulation therapies, today announced a st...

brainsway-invests-23m-in-axis-mental-health-clinics-with-option-for-1m-more
BrainsWay Invests $2.3M In Axis Mental Hea...
08/20/2025 11:38:37

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasiv...

breaking-down-brainsway-4-analysts-share-their-views
Breaking Down BrainsWay: 4 Analysts Share ...
08/14/2025 19:01:33

northland-capital-markets-maintains-outperform-on-brainsway-raises-price-target-to-19
Northland Capital Markets Maintains Outper...
08/14/2025 18:05:37

Northland Capital Markets analyst Carl Byrnes maintains BrainsWay (NASDAQ:BWAY) with a Outperform and raises the price targe...

hc-wainwright--co-maintains-buy-on-brainsway-raises-price-target-to-17
HC Wainwright & Co. Maintains Buy on Brain...
08/14/2025 11:24:04

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target ...

brainsway-raises-fy2025-sales-guidance-from-49000m-51000m-to-50000m-52000m
BrainsWay Raises FY2025 Sales Guidance fro...
08/13/2025 11:32:29

BrainsWay (NASDAQ:BWAY) raises FY2025 sales outlook from $49.000 million-$51.000 million to $50.000 million-$52.000 million.

brainsway-q2-eps-005-inline-sales-12632m-beat-12357m-estimate
BrainsWay Q2 EPS $0.05, Inline, Sales $12....
08/13/2025 11:32:03

BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.05 per share which met the analyst consensus estimate. This is a 150 ...

Core News & Articles
Earnings Scheduled For August 13, 2025
08/13/2025 08:32:30

hc-wainwright--co-reiterates-buy-on-brainsway-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Brai...
06/12/2025 11:08:13

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $16 price tar...

brainsway-sees-comparable-results-between-accelerated-and-standard-deep-tms-in-major-depression-patients
BrainsWay Sees Comparable Results Between ...
06/11/2025 11:33:27

hc-wainwright--co-reiterates-buy-on-brainsway-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Brai...
06/09/2025 12:27:18

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $16 price tar...

brainsway-enters-into-strategic-equity-financing-agreement-with-stella-mso-to-invest-5m-in-stella
Brainsway Enters Into Strategic Equity Fin...
06/04/2025 11:35:21

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasiv...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
05/23/2025 12:08:30

brainsway-affirms-fy2025-sales-guidance-of-4900m-5100m-vs-17975m-est
BrainsWay Affirms FY2025 Sales Guidance of...
05/13/2025 11:32:21

BrainsWay (NASDAQ:BWAY) affirms FY2025 sales outlook from $49.00 million-$51.00 million to $49.00 million-$51.00 million vs $17...

brainsway-q1-eps-002-misses-009-estimate-sales-1154m-miss-4139m-estimate
BrainsWay Q1 EPS $0.02 Misses $0.09 Estima...
05/13/2025 11:31:54

BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.09 by ...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

hc-wainwright--co-reiterates-buy-on-brainsway-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Brai...
03/12/2025 11:40:00

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $16 price tar...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION